Oncology
Transforming growth factor beta 1 accelerates tumor metastasis
Published in Gene Therapy Weekly, March 3rd, 2005
According to a study from the United States, "to address the role of transforming growth factor (TGF) beta in the progression of established tumors while avoiding the confounding inhibitory effects of TGF-beta on early transformation, we generated doxycycline (DOX)-inducible triple transgenic mice in which active TGF-beta1 expression could be conditionally regulated in mouse mammary tumor cells transformed by the polyomavirus middle T antigen."
"DOX-mediated induction of TGF-beta1 for as little as 2 weeks increased lung metastases >10-fold without a detectable...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
Source: Gene Therapy Weekly (2005-03-03)
More Articles from Gene Therapy Weekly
- Anthrax Risk Factors
Host ARAP3 production makes cells vulnerable to anthrax toxin - Brain Cancer
The attenuated adenovirus ONYX-015 fights glioma proliferation - Cancer Therapy
Fusion transgene elicits a robust immunological response to tumor cells - Gene Transfer
Gene transduction corrects cells from patients with Wiskott-Aldrich syndrome - Genetic Engineering
Genetically modified cytolytic T cells recognize and kill glioblastoma - Acute Myeloid Leukemia
XPD genetic variation predicts treatment outcome and AML risk after chemotherapy - More from this issue of Gene Therapy Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
